Giorgia Pepe

Dr. Giorgia Pepe

University of Messina (Italy)
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2021 in Genes
Verified
Journal Article
Open access
PDF file
CCCELESTE CASTO
CELESTE CASTO
Giorgia PepeGiorgia Pepe
Giorgia Pepe
APAlessandra Li Pomi
Alessandra Li Pomi
Domenico CoricaDomenico Corica
Domenico Corica
TATommaso Aversa
Tommaso Aversa
Malgorzata WasniewskaMalgorzata Wasniewska
Malgorzata Wasniewska
Autoimmune thyroid diseases (AITDs), including Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), are the most common cause of acquired thyroid disorder during childhood and adolescence. Our purpose was to assess the main features of AITDs when they occur in association with genetic syndromes. We conducted a systematic review of the literature, covering the last 20 years, through MEDLINE via PubMed and EMBASE databases, in order to identify studies focused on the relation between AITDs and genetic syndromes in children and adolescents. From the 1654 references initially identified, 90 articles were selected for our final evaluation. Turner syndrome, Down syndrome, Klinefelter syndrome, neurofibromatosis type 1, Noonan syndrome, 22q11.2 deletion syndrome, Prader–Willi syndrome, Williams syndrome and 18q deletion syndrome were evaluated. Our analysis confirmed that AITDs show peculiar phenotypic patterns when they occur in association with some genetic disorders, especially chromosomopathies. To improve clinical practice and healthcare in children and adolescents with genetic syndromes, an accurate screening and monitoring of thyroid function and autoimmunity should be performed. Furthermore, maintaining adequate thyroid hormone levels is important to avoid aggravating growth and cognitive deficits that are not infrequently present in the syndromes analyzed.

1 April 2020 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
Giorgia PepeGiorgia Pepe
Giorgia Pepe
DCDomenico Corica
Domenico Corica
LSLuisa De Sanctis
Luisa De Sanctis
MSMariacarolina Salerno
Mariacarolina Salerno
MFMaria Felicia Faienza
Maria Felicia Faienza
MWMalgorzata Wasniewska
Malgorzata Wasniewska
Objective: To evaluate the prevalence and natural course of autoimmune and non-autoimmune subclinical hypothyroidism (SH) in Down syndrome (DS) children and adolescents. Design: Prospective multicenter study. Methods: For the study, 101 DS patients with SH (TSH 5–10 mIU/L; FT4 12–22 pmol/L), aged 2–17 years at SH diagnosis were enrolled. Annual monitoring of TSH, FT4, BMI, height, and L-thyroxine dose was recorded for 5 years. Thyroid autoimmunity was tested at diagnosis and at the end of follow-up. Results: Thirty-seven out of 101 patients displayed autoantibody positivity (group A); the remaining 64 were classified as non-autoimmune SH (group B). Group A was characterized by higher median age at SH diagnosis and by more frequent family history of thyroid disease (6.6 vs 4.7 years, P = 0.001; 32.4% vs 7.8%, P = 0.001 respectively), whereas congenital heart defects were more common in group B (65.6% vs 43.2%, P = 0.028). Gender, median BMI (SDS), height (SDS), FT4, and TSH were similar in both groups. At the end of follow-up: 35.1% of group A patients developed overt hypothyroidism (OH) vs 17.2% of group B (P = 0.041); 31.25% of group B vs 10.8% of group A became biochemically euthyroid (P = 0.02); and 37.8% of group A vs 51.5% of group B still had SH condition (P = 0.183). Logistic regression suggested autoimmunity (OR = 3.2) and baseline TSH values (OR = 1.13) as predictive factors of the evolution from SH to OH. Conclusions: In DS children, non-autoimmune SH showed higher prevalence and earlier onset. The risk of thyroid function deterioration over time seems to be influenced by thyroid autoimmunity and higher baseline TSH values.

10 February 2022 in Endocrine
Verified
Journal Article
Closed access
PDF file
Giorgia PepeGiorgia Pepe
Giorgia Pepe
MCMariarosa Calafiore
Mariarosa Calafiore
MVMaria Rosa Velletri
Maria Rosa Velletri
DCDomenico Corica
Domenico Corica
MVMariella Valenzise
Mariella Valenzise
TATommaso Aversa
Tommaso Aversa

6 August 2019 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
GZGiuseppina Zirilli
Giuseppina Zirilli
GSGiuseppina SALZANO
Giuseppina SALZANO
Domenico CoricaDomenico Corica
Domenico Corica
GPGiovanni Battista Pajno
Giovanni Battista Pajno
CMCristina Mignosa
Cristina Mignosa
GCGiuseppe Crisafulli
Giuseppe Crisafulli
Thyroid cancer (TC) in childhood is a rare disease characterized by an excellent prognosis. Thyroid nodules in children, although less common than in adults, have a greater risk of malignancies, particularly in those cases associated with anamnestic, clinical and ultrasonographic risk factors. Among the factors, which have been found to be linked with an increased relative risk of TC in children, an important role seems to be possibly played by an underlying nodular Hashimoto’s thyroiditis (HT) and by the serum levels of TSH. Aim of this Commentary was to specifically address this last point. According to the available pediatric literature on the relationships between these risk factors and phenotypical expression of TC in children, it is possible to conclude that: 1) It is not completely clarified if HT per se predisposes to malignancy or if it represents an incidental histologic finding in cases with TC or if it may be the result of an immune response against tumoral cells. 2) It is unclear whether phenotypic expression of TC is more severe in the cases with associated HT but normal TSH serum levels. 3) Persistently elevated TSH levels play an independent role as predictors of the likelihood of TC, especially in children but also in adults. 4) Patients with nodular HT and subclinical hypothyroidism need to be treated with Levothyroxine in order to prevent the development of both TC and severe thyroid dysfunctions.

27 August 2020 in Endocrine
Verified
Journal Article
Closed access
PDF file
ATAngelo Tropeano
Angelo Tropeano
ARAnna Maria Roszkowska
Anna Maria Roszkowska
TATommaso Aversa
Tommaso Aversa
Domenico CoricaDomenico Corica
Domenico Corica
Giorgia PepeGiorgia Pepe
Giorgia Pepe
Malgorzata WasniewskaMalgorzata Wasniewska
Malgorzata Wasniewska

20 March 2024 in Endocrine
Verified
Journal Article
Open access
PDF file
APAlessandra Li Pomi
Alessandra Li Pomi
PSPerla Scalini
Perla Scalini
SMSalvatore De Masi
Salvatore De Masi
Domenico CoricaDomenico Corica
Domenico Corica
Giorgia PepeGiorgia Pepe
Giorgia Pepe
Stefano StagiStefano Stagi
Stefano Stagi
Purpose: To identify cut-off for basal LH levels and for pelvic ultrasound uterine and ovarian parameters indicating an Hypotalamic–Pituitary–Gonadal (HPG) axis activation as diagnostic of Central Precocious Puberty (CPP). Methods: 248 girls referred for suspected precocious/early puberty who had undergone a GnRH stimulation test were enrolled and divided into three groups: Premature Idiopathic Thelarche (PIT), CPP, and Early Puberty (EA). For every patient basal serum Luteinising Hormone (LH) and Follicle Stimulating Hormone (FSH), basal LH/FSH ratio and pelvic ultrasonographic parameters were also collected. Through the use of Receiver Operating Curves (ROCs) the sensitivity (Se) and specificity (Sp) of basal LH, FSH, LH/FSH ratio and ultrasonographic parameters were evaluated at each level and Area Under the Curve (AUC) was measured. Results: Basal LH model ≥0.14 mIU/mL reached the highest predictability (90.6% and 78.2%, Se and Sp, respectively). Basal LH/FSH ratio ≥0.1 showed a sensitivity of 85.90% and a specificity of 78.14%, while basal FSH cut-off (≥2.36 mIU/mL) had the lowest predictability, with a less favourable sensitivity (71%) and specificity (70.5%). Cut-off point for uterine length as 35 mm, (83.5% and 42.9% of Se and Sp, respectively) was calculated. For ovarian volumes, ROC curves showed very low sensitivity and specificity. Conclusion: A single basal LH measurement under the cut-off limit may be adequate to exclude an HPG axis activation as CPP.